Hua Medicine is a drug developer that focuses on developing a oral drugs - Dorzagliatin or HMS5552 - for the treatment of Type 2 diabetes. The company was founded in 2009 and is headquartered in Shanghai, China.
Headquarters
275 Ai Di Sheng Road
Shanghai; Shanghai;
Postal Code: 201203
Contact Details: Purchase the Hua Medicine (Shanghai) report to view the information.
Website: http://www.huamedicine.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service